Literature DB >> 31152232

Large-scale production of ursodeoxycholic acid from chenodeoxycholic acid by engineering 7α- and 7β-hydroxysteroid dehydrogenase.

Xuan Zhang1, Daidi Fan2, Xiufu Hua3, Tian Zhang4.   

Abstract

7α- and 7β-hydroxysteroid dehydrogenases (HSDHs) are key biocatalysts for the biotransformation of ursodeoxycholic acid (UDCA) from chenodeoxycholic acid (CDCA). Various researches focused on heterogeneously expressed engineering enzymes to epimerize CDCA for UDCA, however not yet applied to further industrial application. In this work, we present the large-scale production of UDCA from CDCA by 7α- and 7β-HSDH enzymatic synthesis. Engineering enzymes were both successfully heterologous overexpressed in Escherichia coli BL21, and the effect of the enzymatic synthesis was investigated. The mass analysis (MS), IR spectrum, 1H NMR and 13C NMR were used to characterize the product. 500-L fermentor fermentation strategy producing a stable supply of HSDH and large-scale production process of UDCA in dozens kilogram class enabled industrial application.

Entities:  

Keywords:  Bile acid epimerization; Chenodeoxycholic acid; Hydroxysteroid dehydrogenase; Kilogram class; Ursodeoxycholic acid

Mesh:

Substances:

Year:  2019        PMID: 31152232     DOI: 10.1007/s00449-019-02151-4

Source DB:  PubMed          Journal:  Bioprocess Biosyst Eng        ISSN: 1615-7591            Impact factor:   3.210


  3 in total

1.  Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis.

Authors:  Ya-Wen Zhang; Ling-Lan Tu; Yi Zhang; Jie-Chao Pan; Gao-Li Zheng; Li-Na Yin
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

Review 2.  Interactive Relationships between Intestinal Flora and Bile Acids.

Authors:  Xiaohua Guo; Edozie Samuel Okpara; Wanting Hu; Chuyun Yan; Yu Wang; Qionglin Liang; John Y L Chiang; Shuxin Han
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

Review 3.  Gut microbiota: A new target for T2DM prevention and treatment.

Authors:  Lulu Liu; Jiheng Zhang; Yi Cheng; Meng Zhu; Zhifeng Xiao; Guangcong Ruan; Yanling Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-11       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.